neuropathy
Along with partners Genome Medical and Invitae, HNF has launched the CMT Genie Project to improve diagnosis and potentially treatment of Charcot-Marie-Tooth disease.
Genome Medical, Hereditary Neuropathy Foundation Partner for Charcot-Marie-Tooth Disease Testing
The CMT Genie Project aims to provide faster and more equitable access to genetic testing for the CMT community via virtual services.
Exome Sequencing of Peripheral Neuropathy Patients IDs Candidate Genes
Baylor researchers turned to exome sequencing to uncover novel peripheral neuropathy-linked mutations and an increased burden of rare variants in patients.
Genetic Variant Linked to Nerve-related Side Effects from Childhood ALL Treatment
Researchers at St. Jude and elsewhere identified a promoter SNP associated with peripheral neuropathy in vincristine-treated children with acute lymphoblastic leukemia.
NYSCF Collaborates with Charcot-Marie-Tooth Association on Stem Cell Biobank
The partners aim to develop a biobank of induced pluripotent stem cells for the group of neuropathy disorders and then to develop personalized drug therapies.